Paid Clinical Trials Birmingham

Discover 899 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 899

Bodewell Products

Recruiting

Sponsor:

University of Alabama at Birmingham

Location:

Birmingham AL

Code:

NCT05566262

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bodewell Calming Cream

PF-08046054

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Birmingham AL, Houston TX, Cleveland OH, Iowa City IAshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

Ribociclib & Endocrine Treatment

Recruiting

PHASE2

Sponsor:

Oana Danciu

Location:

Birmingham AL, Orlando FL, Columbus OH, Fort Wayne INshow 13 more

Code:

NCT05467891

Conditions

Locoregional Recurrence

Hormone Receptor-positive Breast Cancer

HER2-negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ribociclib

Fulvestrant

Anastrozole

Letrozole

Exemestane

Melphalan Injection with Standard ChemotherapyRetinoblastoma

Recruiting

PHASE2

Sponsor:

Children's Oncology Group

Location:

Birmingham AL, Atlanta GA, Memphis TN, Saint Louis MOshow 13 more

Code:

NCT05504291

Conditions

Bilateral Retinoblastoma

Childhood Intraocular Retinoblastoma

Group D Retinoblastoma

Stage I Retinoblastoma

Unilateral Retinoblastoma

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Etoposide

Examination Under Anesthesia

Magnetic Resonance Imaging

LY900023

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Birmingham AL, Atlanta GA, Jacksonville FL, Saint Louis MOshow 23 more

Code:

NCT05999994

Conditions

Neoplasms

Child

Adolescent

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Ramucirumab

Cyclophosphamide

Vinorelbine

Gemcitabine

Docetaxel

Shunt vs. Stent

Recruiting

Sponsor:

Carelon Research

Location:

Birmingham AL, Atlanta GA, Memphis TN, Charlotte NCshow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

Observational Study

Recruiting

Sponsor:

University of Alabama at Birmingham

Location:

Birmingham AL

Code:

NCT05927974

Conditions

Cognitive Impairment

Dementia

ADD

Depression

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Passive testing

Active testing

Bucillamine

Recruiting

PHASE2

Sponsor:

Revive Therapeutics, Ltd.

Location:

Birmingham AL, Madison WI, New York NY, Warwick RIshow 1 more

Code:

NCT02942420

Conditions

Cystinuria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bucillamine

Radiation Therapy with Atezolizumab

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Birmingham AL, Newnan GA, Collierville TN, Southhaven MSshow 100 more

Code:

NCT04310020

Conditions

Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage III Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

AB-101 & B-Cell Depleting mAb

Recruiting

PHASE1

Sponsor:

Artiva Biotherapeutics, Inc.

Location:

Birmingham AL, San Diego CA

Code:

NCT06265220

Conditions

Lupus Nephritis - WHO Class III

Lupus Nephritis - WHO Class IV

Refractory Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AB-101

Cyclophosphamide

Fludarabine

Rituximab

Obinutuzumab